These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38056083)

  • 1. Quality of life in adolescents with narcolepsy type 1- a transversal study in a tertiary hospital.
    Salazar L; Vieira PM; Cascais I; Figueiroa S; Rios M
    Sleep Med; 2024 Jan; 113():215-219. PubMed ID: 38056083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
    Moresco M; Pizza F; Antelmi E; Plazzi G
    Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary.
    Dauvilliers Y; Roth T; Bogan R; Thorpy MJ; Morse AM; Ascencion F; Gudeman J
    J Comp Eff Res; 2024 Sep; 13(9):e240031. PubMed ID: 39088033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of glymphatic function in narcolepsy using DTI-ALPS index.
    Gumeler E; Aygun E; Tezer FI; Saritas EU; Oguz KK
    Sleep Med; 2023 Jan; 101():522-527. PubMed ID: 36535226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1.
    Varallo G; Franceschini C; Rapelli G; Zenesini C; Baldini V; Baccari F; Antelmi E; Pizza F; Vignatelli L; Biscarini F; Ingravallo F; Plazzi G
    Sci Rep; 2024 May; 14(1):11837. PubMed ID: 38783152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of narcolepsy.
    Miyagawa T; Tokunaga K
    Hum Genome Var; 2019; 6():4. PubMed ID: 30652006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of mood, quality of life and executive function among narcolepsy type 1 patients with or without ADHD symptoms in China.
    Qu S; Wang P; Wang M; Li C; Dong X; Xu L; Han F
    Sleep Med; 2022 Sep; 97():47-54. PubMed ID: 35717731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
    Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
    J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.
    Campos JHC; Aguilar ACR; Antoneli F; Truzzi G; Briones MRS; Ferreira RC; Coelho FMS
    BMC Neurol; 2022 Nov; 22(1):439. PubMed ID: 36401198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleep paralysis during naptime as initial symptom of narcolepsy].
    Villalobos-López P; Maldonado-Contreras A
    Rev Neurol; 2023 Jul; 77(s01):S7-S12. PubMed ID: 37477028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating pitolisant as a narcolepsy treatment option.
    de Biase S; Pellitteri G; Gigli GL; Valente M
    Expert Opin Pharmacother; 2021 Feb; 22(2):155-162. PubMed ID: 32941089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. French consensus. Management of patients with hypersomnia: Which strategy?
    Lopez R; Arnulf I; Drouot X; Lecendreux M; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):8-18. PubMed ID: 27865546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial.
    Dauvilliers Y; Lecendreux M; Lammers GJ; Franco P; Poluektov M; Caussé C; Lecomte I; Lecomte JM; Lehert P; Schwartz JC; Plazzi G
    Lancet Neurol; 2023 Apr; 22(4):303-311. PubMed ID: 36931805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.
    Rocca FL; Finotti E; Pizza F; Ingravallo F; Gatta M; Bruni O; Plazzi G
    Sleep; 2016 Jul; 39(7):1389-98. PubMed ID: 27166243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Narcolepsy with and without cataplexy: an uncommon disabling and unrecognized disease].
    Merino-Andréu M; Martínez-Bermejo A
    An Pediatr (Barc); 2009 Dec; 71(6):524-34. PubMed ID: 19892609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.
    Møller LR; Østergaard JR
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):197-201. PubMed ID: 19364297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.